Valuation: Sopharma AD

Market Cap 1.9B 1.14B 1B 934M 857M 1.61B 110B 1.63B 11.09B 4.33B 54.12B 4.29B 4.2B 187B P/E 2024
12.3x
P/E 2025 7.16x
Enterprise Value 2.44B 1.47B 1.29B 1.2B 1.1B 2.07B 141B 2.1B 14.24B 5.56B 69.51B 5.51B 5.39B 240B EV / Sales 2024
0.66x
EV / Sales 2025 0.76x
Free-Float
31.06%
Yield 2024
2.68%
Yield 2025 -
1 day+2.70%
1 week+0.53%
Current month-1.55%
1 month-1.55%
3 months+10.79%
6 months+2.15%
Current year+33.37%
1 week 1.84
Extreme 1.845
1.92
1 month 1.84
Extreme 1.845
1.94
Current year 1.41
Extreme 1.41
2
1 year 1.21
Extreme 1.212
2
3 years 0.9
Extreme 0.9036
2
5 years 0.58
Extreme 0.5792
2
10 years 0.41
Extreme 0.4087
2
Manager TitleAgeSince
Chief Executive Officer 42 01/10/2000
Director of Finance/CFO - 01/01/2002
Chief Administrative Officer - -
Director TitleAgeSince
Chairman 42 19/05/2010
Director/Board Member 63 19/05/2010
Director/Board Member 61 12/07/2011
Date Insider Type Main position Quantity % Market Cap.
9/30/20 A
Donev Investments Ad
BuyCompany 25,489 0.0189%
9/30/20 A Buy

Chief Executive Officer

12,000 0.0089%
9/29/20 A
Donev Investments Ad
BuyCompany 9,000 0.0067%
Change 5-day change 1-year change 3-year change Capi.($)
+2.70%+0.53%+51.29%+107.17% 1.11B
-1.33%-0.59%-23.55%-27.66% 15.25B
-2.62%-0.60%-31.28%-33.86% 7.07B
+0.63%-2.90%-22.71%-8.80% 5.86B
-1.00%+4.56%-10.59%-29.48% 3.94B
-0.16%+0.22%-30.21%-47.79% 3.16B
-1.55%-0.92%+5.75%-31.47% 3.14B
+0.71%-7.44%-42.27%-18.04% 2.93B
+1.72%+3.47%-13.46%+5.17% 2.57B
+2.56%-0.17%+99.46% - 2.5B
Average +0.17%-1.15%-1.76%-9.42% 4.75B
Weighted average by Cap. -0.60%-2.02%-14.43%-22.19%

Financials

2024 2025
Net sales 2.14B 1.28B 1.13B 1.05B 963M 1.81B 124B 1.84B 12.46B 4.87B 60.84B 4.82B 4.72B 210B 2.63B 1.58B 1.39B 1.29B 1.19B 2.23B 152B 2.26B 15.34B 5.99B 74.86B 5.94B 5.81B 259B
Net income 77.85M 46.75M 41.06M 38.19M 35.04M 65.84M 4.5B 66.86M 453M 177M 2.21B 176M 172M 7.65B 134M 80.19M 70.43M 65.5M 60.11M 113M 7.72B 115M 778M 304M 3.8B 301M 295M 13.13B
Net Debt 444M 267M 234M 218M 200M 376M 25.69B 381M 2.59B 1.01B 12.63B 1B 980M 43.67B 541M 325M 286M 266M 244M 458M 31.31B 465M 3.15B 1.23B 15.39B 1.22B 1.19B 53.22B
Logo Sopharma AD
Sopharma AD, formerly Sopharma AD Sofia, is a Bulgaria-based company engaged in the generic pharmaceutical industry. The Company specializes in the production and trade of medical substances and finished drug forms, as well as research and development in the field of medical products. Through the ampoule plant, tablet plant and the plant in Vrabevo it produces medicines, such as analgesics, antipyretics, cardiovascular medicines as well as drugs for respiratory disease treatment, among others. The Company offers its products under the brand Tribestan, Nivalin and Tabex, among others. In addition, it specializes in the gamma-sterilization of medical materials. It is the parent company of Sopharma Group and operates domestically and abroad in such countries as Russian Federation, Poland, Ukraine, Serbia, the United States and the United Kingdom, among others.
Employees
6,005
Date Price Change Volume
24/07/26 €1.900 +2.70% 30,240
23/07/26 €1.850 -1.07% 4,002
22/07/26 €1.870 -1.58% 8,953
21/07/26 €1.900 +0.26% 265
20/07/26 €1.895 +0.26% 270

Annual profits - Rate of surprise